Expansion of FasL-Expressing CD5+ B Cells in Type 1 Diabetes Patients

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2017.00402
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

NFAT2 and STAT3 Control Type 2 Cytokines in CD5 B Cells

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2010English

B Cells and Type 1 Diabetes …in Mice and Men

Immunology Letters
AllergyImmunology
2014English

Expansion of CD4+CD25+FOXP3+ Regulatory T Cells in Infants of Mothers With Type 1 Diabetes

Pediatric Diabetes
Internal MedicinePediatricsEndocrinologyPerinatologyChild HealthMetabolismDiabetes
2012English

Reduced Fas Ligand-Expressing Splenic CD5+ B Lymphocytes in Severe Collagen-Induced Arthritis

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2009English

CD5 Positive B Cells in Patients With Rheumatoid Arthritis: Phorbol Ester Mediated Enhancement of Detection.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1987English

Circulating Endothelial Cells Are Elevated in Patients With Type 1 Diabetes Mellitus

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2010English

A Novel Multimeric Form of FasL Modulates the Ability of Diabetogenic T Cells to Mediate Type 1 Diabetes in an Adoptive Transfer Model

Molecular Immunology
ImmunologyMolecular Biology
2007English

NK Cells and Type 1 Diabetes

Clinical and Developmental Immunology
2006English

Generation of Stem Cell-Derived Β-Cells From Patients With Type 1 Diabetes

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy